"Emetics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that cause vomiting. They may act directly on the gastrointestinal tract, bringing about emesis through local irritant effects, or indirectly, through their effects on the chemoreceptor trigger zone in the postremal area near the medulla.
| Descriptor ID |
D004639
|
| MeSH Number(s) |
D27.505.696.329 D27.505.696.663.050.225 D27.505.954.427.270 D27.505.954.483.560
|
| Concept/Terms |
Emetics- Emetics
- Emetic Agents
- Agents, Emetic
- Emetic Drugs
- Drugs, Emetic
Emetic Effect- Emetic Effect
- Effect, Emetic
- Emetic Effects
- Effects, Emetic
|
Below are MeSH descriptors whose meaning is more general than "Emetics".
Below are MeSH descriptors whose meaning is more specific than "Emetics".
This graph shows the total number of publications written about "Emetics" by people in this website by year, and whether "Emetics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 2 | 0 | 2 |
| 2007 | 0 | 3 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 2 | 4 |
| 2015 | 0 | 1 | 1 |
| 2016 | 2 | 3 | 5 |
| 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Emetics" by people in Profiles.
-
Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy. Jpn J Clin Oncol. 2018 Oct 01; 48(10):950-952.
-
Genotypic heterogeneity of emetic toxin producing Bacillus cereus isolates from China. FEMS Microbiol Lett. 2017 01; 364(1).
-
2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. Support Care Cancer. 2017 01; 25(1):297-301.
-
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy. Support Care Cancer. 2017 01; 25(1):289-294.
-
2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents. Support Care Cancer. 2017 01; 25(1):271-275.
-
Infusion treatments and deep brain stimulation in Parkinson's Disease: The role of nursing. Geriatr Nurs. 2016 Nov - Dec; 37(6):434-439.
-
A prospective observational study on chemotherapy-induced nausea and vomiting (CINV) in patients with gynecologic cancer by the CINV Study Group of Japan. Gynecol Oncol. 2016 Mar; 140(3):559-64.
-
A double-blind randomized Phase II study of olanzapine 10 mg versus 5 mg for emesis induced by highly emetogenic chemotherapy. Jpn J Clin Oncol. 2015 Feb; 45(2):229-31.
-
The genetic diversity of cereulide biosynthesis gene cluster indicates a composite transposon Tnces in emetic Bacillus weihenstephanensis. BMC Microbiol. 2014 Jun 07; 14:149.
-
Integration of vestibular and emetic gastrointestinal signals that produce nausea and vomiting: potential contributions to motion sickness. Exp Brain Res. 2014 Aug; 232(8):2455-69.